In vitro characterization of the human skeletal stem cell-like properties of primary bone-derived mesenchymal stem /stromal cells in patients with late and early hip osteoarthritis

Jasenc, Lara (avtor), Stražar, Klemen (avtor), Trebše, Rihard (avtor), Mihelič, Anže (avtor), Mihalič, Rene (avtor), Jeras, Matjaž (avtor), Zupan, Janja (avtor)

Human skeletal stem cells (hSSCs) were recently identified as podoplanin (PDPN)/CD73/CD164-positive and CD146-negative cells that decline with age, and play a role in the pathogenesis of osteoarthritis (OA). The aim of this study was to identify the hSSC-like properties of bone-derived mesenchymal stem/stromal cells (MSCs) of patients with late and early OA. Methods: First, we performed gene expression profiling for the hSSC markers in 32 patients with late and early OA, and donors without OA. Having identified the low expression of hSSC markers in late OA patients, we further performed trilineage differentiation and immunophenotyping for hSSC makers in the selected subsets from each donor group. Results: Our results show no differences in osteogenesis, chondrogenesis, and adipogenesis between the MSCs from the three groups. However, the immunophenotyping shows lower CD164 in MSCs from early OA patients in comparison with late and no OA subjects (p = 0.002 and p = 0.017). Conclusions: Our study shows that the in vitro hSSC-like properties of bone-derived MSCs are similar in patients with early and late OA, and in donors without OA. However, the lower percentage of CD164-positive MSCs in early OA patients indicates the potential of CD164 as a marker of the onset of OA.

• Jezik: Angleški jezik
• Ključne besede: human skeletal stem cells (hSSCs), late osteoarthritis (OA), early OA, bone-derived, mesenchymal stem/stromal cells (MSCs), podoplanin (PDPN), CD73, CD164, CD146, trilineage, differentiation, immunophenotyping
• Vrsta gradiva: Članek v reviji
• Tipologija: 1.01 - Izvirni znanstveni članek
• Organizacija: FFA - Fakulteta za farmacijo ; MF - Medicinska fakulteta
• Različica publikacije: Objavljena publikacija
• Datum objave: 01.01.2022
• Leto izida: 2022
• Št. strani: Str. 1-15
• Številčenje: Vol. 12, iss. 6, art. 899
• PID: 20.500.12556/RUL-140238
• UDK: 617.3
• ISSN pri članku: 2075-1729
• DOI: 10.3390/life12060899
• COBISS.SI-ID: 112107267
• Datum objave v RUL: 13.09.2022

Gradivo je del revije

• Naslov: Life
• Skrajšan naslov: Life
• Založnik: MDPI
• ISSN: 2075-1729
• COBISS.SI-ID: 519982617

Licence

• Licenca: CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
• Povezava: http://creativecommons.org/licenses/by/4.0/deed.sl
• Opis: To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.
• Začetek licenciranja: 13.09.2022

Sekundarni jezik

• Jezik: Slovenski jezik
• Ključne besede: artroza, kostne matične celice, kolk, človeške skeletne izvorne celice (hSSC), pozni osteoartritis (OA), zgodnji OA, mezenhimske matične/stromalne celice (MSC) iz kosti, podoplanin (PDPN), CD73, CD164, CD146, trirodnost, diferenciacija, imunofenotipizacija

Projekti

• Financer: ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
• Številka projekta: J3-1749-2019
• Naslov: Mezenhimske matične celice-nosilci endogene regenerativne sposobnosti tkiv v boju proti staranju mišično-skeletnega sistema

• Financer: ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
• Številka projekta: P1-0420-2022
• Naslov: Napredna imunološka zdravila in celični pristopi v farmaciji